Cardlytics Announces Fourth Quarter and Fiscal Year 2020 Financial Results

Go back to Cardlytics Announces Fourth Quarter and Fiscal Year 2020 Financial Results

Cardlytics (CDLX) Misses Q4 EPS by 2c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Above Consensus

March 1, 2021 6:43 AM EST

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $67.1 million versus the consensus estimate of $60.89 million.

Fourth Quarter 2020 Financial Results

Total revenue was $67.1 million, a decrease of (3.2)%, compared to $69.3 million in the fourth quarter of 2019.Net loss attributable to common stockholders was $(6.8) million, or $(0.24) per diluted share, based on 27.7 million weighted-average common shares outstanding, compared to a net income attributable to common stockholders of $3.4 million, or $0.12 per diluted... More